Literature DB >> 19413580

Combined liver-kidney and liver transplantation in patients with renal failure outcomes in the MELD era.

Timothy M Schmitt1, Sean C Kumer, Abdullah Al-Osaimi, Neeral Shah, Curtis K Argo, Carl Berg, Timothy L Pruett, Patrick G Northup.   

Abstract

With the implementation of the Model for End-Stage Liver Disease (MELD) scoring system, the number of combined liver-kidney transplants (CLKT) has increased dramatically. The United Network for Organ Sharing (UNOS) dataset was analysed for adult recipients with renal failure for the period between February 2002 and April 2006. This group was subdivided into patients on hemodialysis (HD) and to those not on HD prior to transplantation. All recipients in renal failure (serum creatinine > or =2.5 mg/dl) at the time of transplantation were included. A total of 1397 subjects were in renal failure but not on HD (18% received a CLKT, 82% underwent LT alone). Another 1740 subjects were on HD prior to transplantation (41% received a CLKT while 59% received a LT). In dialysis-dependent recipients, Cox regression analysis demonstrated CLKT had an independent protective effect. In subjects on HD, CLKT had improved survival at 1 year (79.4 vs. 73.7%, P = 0.004). In patients in renal failure without HD, CLKT was not protective. CLKT subjects had a nonsignificant difference in survival as compared with patients who had undergone liver transplantation alone, at 1 year (81.0% vs. 78.8%, P > 0.10). In subjects undergoing CLKT, there was improved survival at 1 year as compared with LT-alone patients on hemodialysis; however, in patients with renal failure, but not on hemodialysis, there was no difference in survival when comparing CLKT to LT-alone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19413580     DOI: 10.1111/j.1432-2277.2009.00887.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  17 in total

Review 1.  Kidney Failure and Liver Allocation: Current Practices and Potential Improvements.

Authors:  Varun Saxena; Jennifer C Lai
Journal:  Adv Chronic Kidney Dis       Date:  2015-09       Impact factor: 3.620

2.  Propensity score-based survival benefit of simultaneous liver-kidney transplant over liver transplant alone for recipients with pretransplant renal dysfunction.

Authors:  Pratima Sharma; Xu Shu; Douglas E Schaubel; Randall S Sung; John C Magee
Journal:  Liver Transpl       Date:  2016-01       Impact factor: 5.799

3.  Simultaneous liver-kidney versus liver transplantation alone in patients with end-stage liver disease and kidney dysfunction not on dialysis.

Authors:  A L Mindikoglu; J P Raufman; S L Seliger; C D Howell; L S Magder
Journal:  Transplant Proc       Date:  2011-09       Impact factor: 1.066

4.  End-stage renal disease after liver transplantation in patients with pre-transplant chronic kidney disease.

Authors:  Ranjeeta Bahirwani; Kimberly A Forde; Yifei Mu; Fred Lin; Peter Reese; David Goldberg; Peter Abt; K Rajender Reddy; Matthew Levine
Journal:  Clin Transplant       Date:  2014-01-02       Impact factor: 2.863

Review 5.  Pre-transplant kidney function predicts chronic kidney disease after liver transplant: meta-analysis of observational studies.

Authors:  Fabrizio Fabrizi; Vivek Dixit; Paul Martin; Piergiorgio Messa
Journal:  Dig Dis Sci       Date:  2011-01-08       Impact factor: 3.199

6.  Recipient survival and graft survival are not diminished by simultaneous liver-kidney transplantation: an analysis of the united network for organ sharing database.

Authors:  Eric F Martin; Jonathan Huang; Qun Xiang; John P Klein; Jasmohan Bajaj; Kia Saeian
Journal:  Liver Transpl       Date:  2012-08       Impact factor: 5.799

7.  Renal outcomes of simultaneous liver-kidney transplantation compared to liver transplant alone for candidates with renal dysfunction.

Authors:  Todd V Brennan; Keri E Lunsford; Parsia A Vagefi; Alan Bostrom; Michael Ma; Sandy Feng
Journal:  Clin Transplant       Date:  2014-11-17       Impact factor: 2.863

8.  Comparative effectiveness of liver transplant strategies for end-stage liver disease patients on renal replacement therapy.

Authors:  Yaojen Chang; Lorenzo Gallon; Colleen Jay; Kirti Shetty; Bing Ho; Josh Levitsky; Talia Baker; Daniela Ladner; John Friedewald; Michael Abecassis; Gordon Hazen; Anton I Skaro
Journal:  Liver Transpl       Date:  2014-09       Impact factor: 5.799

9.  Baseline and Center-Level Variation in Simultaneous Liver-Kidney Listing in the United States.

Authors:  Xun Luo; Allan B Massie; Christine E Haugen; Rashikh Choudhury; Jessica M Ruck; Ashton A Shaffer; Sheng Zhou; Dorry L Segev; Jacqueline M Garonzik-Wang
Journal:  Transplantation       Date:  2018-04       Impact factor: 4.939

10.  Reduced impact of renal failure on the outcome of patients with alcoholic liver disease undergoing liver transplantation.

Authors:  Jaeyoun Cheong; Joseph A Galanko; Sumant Arora; Joaquin Cabezas; Nambi J Ndugga; Michael R Lucey; Paul H Hayashi; Alfred Sidney Barritt; Ramon Bataller
Journal:  Liver Int       Date:  2016-07-04       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.